Table 4

Changes of six introretinal layers in each patient during follow-up periods

No.	Eye	RNFL			GCIPL			INL			OPL			ONL			PR
No.	Eye	Ba	4M	6M	Ba	4M	6M	Ba	4M	6M	Ba	4M	6M	Ba	4M	6M	Ba	4M	6M
1	OD	1.30	1.36	1.29	2.00	1.91	2.05	0.90	0.88	0.82	0.85	0.74	0.81	2.01	2.18	2.05	1.37	1.39	1.32
1	OS	1.30	1.30	1.27	2.03	1.96	2.10	0.87	0.89	0.87	0.82	0.80	0.79	2.07	2.15	2.11	1.33	1.40	1.30
2	OD	1.19	1.20	1.21	1.92	1.97	1.91	0.89	0.82	0.86	0.66	0.68	0.60	1.97	1.96	2.00	1.22	1.21	1.21
2	OS	1.44	1.37	1.43	2.19	2.14	2.13	0.82	0.81	0.82	0.98	0.94	0.90	1.78	1.80	1.81	1.32	1.34	1.33
3	OD	1.13	1.17	1.05	2.13	2.13	2.22	1.05	1.06	1.08	0.73	0.88	0.70	2.35	2.23	2.39	1.21	1.37	1.22
3	OS	1.09	1.15	1.15	2.10	2.02	2.05	0.99	1.01	1.06	0.72	0.81	0.78	2.29	2.26	2.30	1.24	1.31	1.29
4	OD	1.03	0.99	0.97	1.95	1.92	1.85	0.87	0.88	0.95	0.76	0.85	0.70	1.95	1.95	2.15	1.23	1.26	1.21
4	OS	1.16	1.04	1.05	1.89	1.99	1.89	0.93	0.93	0.92	0.63	0.62	0.73	2.06	2.11	2.02	1.15	1.12	1.25
5	OD	1.19	1.10	1.08	1.96	2.05	2.07	0.81	1.15	1.13	0.82	0.76	0.83	2.08	2.21	2.11	1.34	1.27	1.33
5	OS	1.18	1.04	1.07	2.13	1.77	1.77	1.02	0.92	0.91	0.76	0.75	0.71	2.24	2.13	2.18	1.34	1.33	1.30
6	OD	0.85	0.94	0.92	1.85	1.77	1.89	0.76	0.72	0.64	0.80	0.84	0.86	1.68	1.68	1.71	1.12	1.14	1.16
6	OS	0.95	0.90	0.89	1.79	1.84	1.86	0.77	0.79	0.80	0.83	0.86	0.85	1.66	1.76	1.76	1.16	1.19	1.18
7	OD	1.16	1.20	1.18	1.98	2.06	2.06	0.98	0.85	0.76	0.64	1.01	0.86	2.16	1.81	1.86	1.21	1.32	1.31
7	OS	1.16	1.14	1.12	2.02	2.05	2.02	0.85	0.89	0.92	0.68	0.72	0.71	2.01	2.00	2.00	1.19	1.21	1.21
8	OD	1.27	1.20	1.36	2.06	2.20	2.14	0.88	0.84	0.85	1.03	1.13	0.97	1.85	1.76	1.79	1.47	1.32	1.32
8	OS	1.42	1.36	1.34	2.15	2.20	2.18	0.89	0.86	0.88	0.83	1.00	1.01	1.93	1.78	1.83	1.26	1.31	1.32

Ba, baseline; GCIPL, ganglion cell-inner plexiform layer; INL, inner nuclear layer; 4M, 4 months; 6M, 6 months; OD, right eye; ONL, outer nuclear layer; OPL, outer plexiform layer; OS, left eye; PR, retinal photoreceptor layer; RNFL, retinal nerve fiber layer.